| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Piotr Zimniak | |
| Sanjay Awasthi | |||
| Jyotsana Singhal | |||
| Jizhong Cheng | |||
| Sharad Singhal | |||
| Yogesh Awasthi | |||
| P2860 | cites work | Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin | Q22254720 |
| RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes | Q24291401 | ||
| Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral | Q24318512 | ||
| Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity | Q24337472 | ||
| Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line | Q24338329 | ||
| Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases | Q24651430 | ||
| RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis | Q28141762 | ||
| HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo | Q28181223 | ||
| Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76 | Q28182524 | ||
| Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity | Q28182550 | ||
| Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells | Q28203126 | ||
| RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis | Q28207629 | ||
| RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics | Q28215022 | ||
| A putative effector of Ral has homology to Rho/Rac GTPase activating proteins | Q28512740 | ||
| Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus | Q28579981 | ||
| Biochemistry of multidrug resistance mediated by the multidrug transporter | Q29616476 | ||
| The multidrug resistance protein family. | Q30323786 | ||
| Differential expression of sphingolipids in MRP1 overexpressing HT29 cells | Q30881625 | ||
| REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells | Q30938786 | ||
| Identification of membrane-anchoring domains of RLIP76 using deletion mutant analyses | Q33210207 | ||
| Monitoring interactions at ATP-dependent drug efflux pumps | Q34023770 | ||
| Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein | Q34130602 | ||
| POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis | Q34393707 | ||
| A Ral guanine exchange factor-Ral pathway is conserved in Drosophila melanogaster and sheds new light on the connectivity of the Ral, Ras, and Rap pathways | Q34463200 | ||
| Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. | Q34608865 | ||
| Small cell carcinoma of the bladder: a case report and a literature review | Q35121537 | ||
| Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance | Q35179100 | ||
| Resected non-small cell lung cancer: need for adjuvant lymph node treatment? From hope to reality. | Q35581379 | ||
| Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters | Q36721034 | ||
| Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1 | Q36744205 | ||
| Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76 | Q36982690 | ||
| Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates | Q37146994 | ||
| RLIP76 in defense of radiation poisoning | Q37146998 | ||
| Organic anion-transporting ATPase of rat liver. I. Purification, photoaffinity labeling, and regulation by phosphorylation | Q38302679 | ||
| Regression of melanoma in a murine model by RLIP76 depletion | Q38315672 | ||
| The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review | Q39818231 | ||
| Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76. | Q40247154 | ||
| Determinants of differential doxorubicin sensitivity between SCLC and NSCLC. | Q40297526 | ||
| The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer | Q40387322 | ||
| Anthracycline antibiotics in cancer therapy. Focus on drug resistance | Q40388183 | ||
| Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin | Q40410738 | ||
| Combination therapy with probucol prevents adriamycin-induced cardiomyopathy | Q40415594 | ||
| RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer. | Q40459619 | ||
| RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance | Q40512245 | ||
| Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma. | Q40606160 | ||
| HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II. | Q41718693 | ||
| Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences | Q43574003 | ||
| Modulation of glucose-6-phosphate dehydrogenase activity and expression is associated with aryl hydrocarbon resistance in vitro | Q43681979 | ||
| Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress | Q43720112 | ||
| RLIP76 is a major determinant of radiation sensitivity | Q46604639 | ||
| ATP-Dependent colchicine transport by human erythrocyte glutathione conjugate transporter. | Q52221583 | ||
| Cellular predictive factors of drug resistance in non-small cell lung carcinomas. | Q53953903 | ||
| MDR1 gene expression in lung cancer. | Q54346895 | ||
| Lung cancer | Q73858423 | ||
| Role of paxillin in metabolic oxidative stress-induced cytoskeletal reorganization: involvement of SAPK signal transduction pathway and PTP-PEST gene expression | Q74233648 | ||
| ATP-Dependent human erythrocyte glutathione-conjugate transporter. I. Purification, photoaffinity labeling, and kinetic characteristics of ATPase activity | Q74457045 | ||
| ATP-Dependent human erythrocyte glutathione-conjugate transporter. II. Functional reconstitution of transport activity | Q74457048 | ||
| P921 | main subject | doxorubicin | Q18936 |
| lung cancer | Q47912 | ||
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76 |
| Q41576686 | Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells |
| Q41109739 | Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress |
| Q59799450 | Anticancer activity of 2'-hydroxyflavanone towards lung cancer |
| Q39322595 | Cell type-specific effects of Adenosine 5'-triphosphate and pyrophosphate on the antitumor activity of doxorubicin |
| Q37457650 | Homeobox protein VentX induces p53-independent apoptosis in cancer cells |
| Q35227377 | Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis |
| Q35787969 | Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells. |
| Q92382628 | Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells |
| Q39215770 | Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells |
| Q34167090 | Metadherin interference inhibits proliferation and enhances chemo-sensitivity to doxorubicin in diffuse large B cell lymphoma |
| Q38830661 | MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN. |
| Q34460758 | Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer |
| Q49387560 | Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles |
| Q35628908 | Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence |
| Q41646063 | Oxidative stress and lipid peroxidation products in cancer progression and therapy |
| Q60912518 | Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation |
| Q53793272 | Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients. |
| Q34559882 | Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells |
| Q35073746 | Quercetin-induced cardioprotection against doxorubicin cytotoxicity |
| Q39042820 | The mitochondrial cyclophilin D/p53 complexation mediates doxorubicin-induced non-apoptotic death of A549 lung cancer cells |
| Q38823143 | Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing? |
| Q38649748 | Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1. |
Search more.